文献速递认知障碍与痴呆

早老素1 Met146Leu致病性变异家系的体内tau蛋白与神经变性影像研究

In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1 Met146Leu Pathogenic Variant.
PubMed 文献 · Neurology · 2024-11-25

研究纳入同一「N」家系中3例有症状的PSEN1 c.436 A>C p.Met146Leu变异携带者、1例无症状携带者和1例非携带者,均行临床评估、18F-flortaucipir-PET和MRI,3例可行18F-氟脱氧葡萄糖-PET。结果显示有症状携带者均呈晚期阿尔茨海默病tau模式,女性携带者较男性携带者在疾病严重程度和病程相当时起病年龄更早、颞顶叶及额叶tau病理更明显;无症状男性携带者在症状出现前4年tau扫描为阴性。

要点

  • 有症状PSEN1 Met146Leu携带者均表现为晚期阿尔茨海默病tau蛋白模式。
  • 疾病严重程度和病程相当时,女性携带者较男性起病更早、颞顶叶及额叶tau病理更明显。
  • 无症状男性携带者在症状出现前4年tau扫描为阴性,无症状期所有生物标志物均为阴性。

核心结论

  • 在PSEN1 Met146Leu变异携带者中,早期记忆减退期间即存在高皮质tau负荷,而无显著萎缩。
  • 无症状期所有生物标志物均为阴性。
  • 女性较男性tau病理更明显,提示需研究常染色体显性阿尔茨海默病中的性别差异。

研究设计与样本

  • 纳入同一「N」家系中3例有症状的PSEN1 c.436 A>C, p.Met146Leu, NM_000021.4, rs63750306变异携带者、1例无症状携带者和1例非携带者。
  • 所有受试者均接受临床评估、18F-flortaucipir-PET和MRI检查。
  • 3例受试者可行18F-氟脱氧葡萄糖-PET检查。

主要发现

  • 所有有症状携带者均显示晚期阿尔茨海默病tau模式。
  • 有症状女性携带者较男性携带者在疾病严重程度和病程相当时起病年龄更早,颞顶叶和额叶tau病理更明显。
  • 无症状男性携带者在症状出现前4年tau扫描为阴性。
  • 所有个体MRI均未见严重皮质和海马萎缩。
  • 有症状携带者脑代谢显示阿尔茨海默病典型的神经变性模式。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We investigated tau and neurodegeneration patterns and clinical phenotypes in carriers of a specific pathogenic variant in the PSEN1 gene and 1 nonaffected relative. METHODS: We included 3 symptomatic carriers of the c.436 A>C, p.Met146Leu, NM_000021.4, rs63750306 variant in the PSEN1 gene, pathogenic for autosomal dominant Alzheimer disease (AD), 1 asymptomatic carrier of the same variant, and 1 noncarrier, all belonging to the same "N" family. All subjects underwent clinical evaluations, 18F-flortaucipir-PET, and MRI. 18F-fludeoxyglucose-PET was available for 3 cases. RESULTS: All symptomatic carriers showed advanced AD tau patterns. Symptomatic female carriers presented an earlier age at onset and more pronounced tau pathology in temporoparietal and frontal regions than male carriers, at comparable disease severity and duration. The presymptomatic male carrier showed a negative tau scan 4 years before symptom onset. MRI showed no severe cortical and hippocampal atrophy in all individuals. Brain metabolism showed neurodegeneration patterns typical of AD in symptomatic carriers. DISCUSSION: In PSEN1 Met146Leu variant carriers, high cortical tau load, without significant atrophy, was present during early memory deficits. In the asymptomatic phase, all biomarkers were negative. More pronounced tau pathology in female than male individuals highlights the need to investigate sex differences in autosomal dominant AD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Boccalini C, Dodich A, Scheffler M, et al. In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1 Met146Leu Pathogenic Variant. Neurology. 2024. PMID: 39586047. doi:10.1212/WNL.0000000000210103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。